Performance of the genotype MTBDRplus assay directly on sputum specimens from Brazilian patients with tuberculosis treatment failure or relapse

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1606-1608

  De Abreu Maschmann, Raquel ^a,b   Spies, Fernanda Sá ^b   De Souza Nunes, Luciana ^b   Ribeiro, Andrezza Wolowski ^b   Machado, Taís Raquel Marcon ^a   Zaha, Arnaldo ^b   Rossetti, Maria Lucia Rosa ^a,b,c  

^a Fundacao Estadual de Producao e Pesquisa em Saude   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; BACTERIAL DNA; BACTERIAL PROTEIN; CATALASE; INHA PROTEIN, MYCOBACTERIUM; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASE; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BRAZIL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; INHA GENE; INTERMETHOD COMPARISON; KATG GENE; MAJOR CLINICAL STUDY; NONHUMAN; OUTPATIENT; PERFORMANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; RELAPSE; RPOB GENE; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TREATMENT FAILURE; TUBERCULOSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; RECURRENT DISEASE; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; BASE SEQUENCE; BRAZIL; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; RECURRENCE; RIFAMPIN; SEQUENCE ANALYSIS, DNA; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84876745417     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00364-13     Document Type: Article

References (22)

1. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. 2008. Rapid molecular screening for multidrug-resistant tuberculosis in a highvolume public health laboratory in South Africa. Am. J. Respir. Crit. Care. Med. 177:787-792.
2. Tolani MP, D'souza DTB, Mistry NF. 2012. Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect. Dis. 12:9.
3. Huang WL, Chen HY, Kuo YM, Jou R. 2009. Performance assessment of the GenoType MTBDRplus test andDNAsequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 47:2520-2524.
4. Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F. 2009. Performance of the Genotype® MTBDRplus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin. Pathol. 9:2.
5. Ott WP, Jarczewski CA. 2007. Combate à tuberculose sob novo enfoque no Rio Grande do sul. Bol. Epidemiol. 9:1-8.
6. World Health Organization. 2003. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/2003.320. World Health Organization, Geneva, Switzerland.
7. Canetti G, Fox W, Khomenko A, Mahler HT, Menon MK, Mitchison DA, Rist N, Smelov NA. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ. 41:21-43.
8. Dalla Costa ER, Ribeiro MO, Silva MSN, Arnold LS, Rostirolla DC, Cafrune PI, Espinoza RC, Palaci M, Telles MA, Ritacco V, Suffys PN, Lopes ML, Campelo CL, Miranda SS, Kremer K, da Silva PEA, Fonseca LS, Ho JL, Kritski AL, Rossetti MLR. 2009. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol. 9:39.
9. Maschmann RA, Verza M, Silva MS, Sperhacke RD, Ribeiro MO, Suffys PN, Gomes HG, Tortoli E, Marcelli F, Zaha A, Rossetti MLR. 2011. Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay. Mem. Inst. Oswaldo Cruz 106:139-145.
10. Jin J, Zhang Y, Fan X, Diao N, Shao L. Wang F, Hu P, Wang S, Weng X, Zhang W. 2012. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection. Int. J. Tuberc. Lung Dis. 16:521-526.
11. Brossier F, Veziris N, Tuffot-Pernot C, Jarlier V, Sougakoff W. 2006. Performance of the Genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low-and high-level resistance. J. Clin. Microbiol. 44:3659-3664.
12. Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM. 2007. Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin. Microbiol. Infect. 13:620-626.
13. Hillemann D, Rüsch-Gerdes S, Richter E. 2007. Evaluation of the Geno-TypeMTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640.
14. Lacoma A, Garcia-Sierra N, Prat C, Ruiz-Manzano J, Haba L, Rosés S, Maldonado J, Domínguez J. 2008. Genotype MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 46:3660-3667.
15. Miotto P, Piana F, Cirillo DM, Migliori GB. 2008. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 46:393-394.
16. Rigouts L, Hoza AS, De Rijk P, Torrea G, Chonde TM, Basra D, Zignol M, van Leth F, Egwaga SM, Van Deun A. 2011. Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys. Int. J. Tuberc. Lung Dis. 15:959-965.
17. Ling DI, Zwerling AA, Pai M. 2008. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32:1165-1174.
18. Zhang Y, Yew WW. 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13:1320-1330.
19. Machado D, Couto I, Perdigão J, Rodrigues L, Portugal I, Baptista P, Veigas B, Amaral L, Viveiros M. 2012. Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PLoS One 7:e34538. doi:10.1371/journal.pone.0034538.
20. Viveiros M, Portugal I, Bettencourt R, Victor TC, Jordaan AM, Leandro C, Ordway D, Amaral L. 2002. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46:2804-2810.
21. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A. 2009. Mycobacterium tuberculosis Strains with highly discordant rifampin susceptibility test results. J. Clin. Microbiol. 47:3501-3506.
22. Cardoso RF, Cooksey RC, Glenn P, Barco P, Cecon L, Forestiero F, Leite CQF, Sato DN, Shikama ML, Mamizuka EM, Hirata RDC, Hirata MH. 2004. Screening and characterization of mutations in isoniazidresistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother. 48:3373-3381.